Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Genetic Signatures Ltd. ( (AU:GSS) ).
Genetic Signatures Ltd. announced the cessation of 150,000 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This announcement may impact the company’s capital structure, potentially affecting investor perceptions and market positioning.
The most recent analyst rating on (AU:GSS) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Genetic Signatures Ltd. stock, see the AU:GSS Stock Forecast page.
More about Genetic Signatures Ltd.
Genetic Signatures Ltd. operates in the biotechnology industry, focusing on the development and commercialization of molecular diagnostic solutions. The company specializes in providing products for the detection of infectious diseases, leveraging its proprietary 3base™ technology to enhance the speed and accuracy of pathogen detection.
Average Trading Volume: 172,165
Technical Sentiment Signal: Sell
Current Market Cap: A$65.87M
For a thorough assessment of GSS stock, go to TipRanks’ Stock Analysis page.